Promoting access and affordability of healthcare in India

An interesting article from Bio Spectrum magazine based on the 3rd annual BIO India conference, in which participants agreed that compulsory licensing was not an effective means of promoting access or affordability of healthcare as they would broadly undermine incentives for companies and individuals to innovate in India.

Global R&D Convention: a boon for patients or a political nightmare?

The following is an interesting post from the Apothecurry blog on the topic of the global R&D convention proposed by an expert working group of the World Health Organization. In theory, the convention would complement the existing patent system and be of great benefit to patients around the world. In practice, it's easy to imagine how this ideal system could get derailed. The WHO's executive board is scheduled to revisit the idea (and perhaps consider alternatives) in 2013.

The global battle against HIV/AIDS

An interesting op-ed by John Castellani, PhRMA CEO, about the proposed intellectual property provisions in the Trans Pacific Partnership (TPP) trade agreement, innovation and access to medicines. Without appropriate intellectual property protection, further innovations and needed research, progress could be slowed and in some areas stopped — and it is patients who will lose out.

Uniting to combat neglected tropical diseases: public-private partnership

Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade.

Uniting efforts with NTD-endemic countries, partners pledged to bring a unique focus to defeating these diseases and to work together to improve the lives of the 1.4 billion people worldwide affected by NTDs, most of whom are among the world’s poorest.


Subscribe to Patients and Patents RSS